Join to View Full Profile
800 Washington St# 245Boston, MA 02111
Phone+1 617-636-6227
Dr. Elkon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jacob Elkon, MD, is an oncologist based in Boston, MA, specializing in gastrointestinal oncology. He completed his fellowship in Hematology and Medical Oncology and his residency in Internal Medicine at George Washington University after graduating from Mercer University School of Medicine in 2013. Dr. Elkon has served as an Assistant Professor at Tufts Medical Center since 2020 and previously at The GW Medical Faculty Associates. He has contributed several publications to the field, including works focusing on various cancer therapies and case studies in prestigious journals such as The Oncologist, BMJ Case Reports, and Anticancer Research. His research has been cited by other publications multiple times, indicating his active involvement in advancing oncological treatments and understanding.
Education & Training
- George Washington UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019
- George Washington UniversityResidency, Internal Medicine, 2013 - 2016
- Mercer University School of MedicineClass of 2013
Certifications & Licensure
- MA State Medical License 2020 - 2025
- DC State Medical License 2016 - 2020
- VA State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A Multicenter Feasibility Study of a Novel Curriculum for Oncology Trainees Regarding Medical Cannabis.Rushad Patell, Poorva Bindal, Jason Freed, Laura E Dodge, Gayathri Nagaraj
Journal of the National Comprehensive Cancer Network. 2025-03-01 - 7 citationsPhase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer.Jianqing Lin, Jacob Elkon, Brittany Ricart, Erica Palmer, Christian Zevallos-Delgado
The Oncologist. 2021-09-14 - Two distinct histological Richter's transformations 23 years apart in a patient with chronic lymphocytic leukaemia.Umera Thebo, Ralph L. Millett, Jacob Elkon, Faysal Haroun
BMJ Case Reports. 2018-10-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: